List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 651 studies with search of: "Sarcoma"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Isolated Limb Perfusion of Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Soft Tissue Sarcoma of the Arm or Leg
Conditions: Stage IVB Adult Soft Tissue Sarcoma;   Stage IIB Adult Soft Tissue Sarcoma;   Stage IIC Adult Soft Tissue Sarcoma;   Recurrent Adult Soft Tissue Sarcoma;   Stage IVA Adult Soft Tissue Sarcoma;   Stage III Adult Soft Tissue Sarcoma
Interventions: Drug: melphalan;   Drug: tumor necrosis factor
2 Completed Vaccine Therapy and Interleukin-2 With or Without White Blood Cell Transplantation in Treating Patients With Recurrent Sarcomas
Conditions: Recurrent Childhood Rhabdomyosarcoma;   Extraosseous Ewing's Sarcoma/Primitive Neuroectodermal Tumor;   Recurrent Ewing's Sarcoma/Primitive Neuroectodermal Tumor;   Adult Rhabdomyosarcoma;   Recurrent Childhood Soft Tissue Sarcoma;   Alveolar Childhood Rhabdomyosarcoma;   Recurrent Tumors of the Ewing's Family;   Recurrent Adult Soft Tissue Sarcoma
Intervention: Drug: interleukin-2
3 Recruiting Trial of Dasatinib in Advanced Sarcomas
Conditions: Rhabdomyosarcoma;   Malignant Peripheral Nerve Sheath Tumors;   Osteosarcoma;   Chondrosarcoma;   Sarcoma, Ewing's;   Sarcoma, Alveolar Soft Part;   Chordoma;   Epithelioid Sarcoma;   Giant Cell Tumor of Bone;   Hemangiopericytoma;   Gastrointestinal Stromal Tumor (GIST)
Intervention: Drug: Dasatinib
4 Withdrawn Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma
Conditions: Stage III Adult Soft Tissue Sarcoma;   Recurrent Adult Soft Tissue Sarcoma;   Stage IVA Adult Soft Tissue Sarcoma;   Stage IIB Adult Soft Tissue Sarcoma;   Stage IIC Adult Soft Tissue Sarcoma
Interventions: Drug: doxorubicin;   Drug: filgrastim;   Drug: ifosfamide;   Procedure: biological response modifier therapy;   Procedure: brachytherapy;   Procedure: chemotherapy;   Procedure: colony-stimulating factor therapy;   Procedure: conventional surgery;   Procedure: cytokine therapy;   Procedure: intraoperative radiotherapy;   Procedure: radiation therapy;   Procedure: surgery
5 Active, not recruiting Phase 1b/2 Study of AMG 655 With Doxorubicin for the First-Line Treatment of Unresectable Soft Tissue Sarcoma
Conditions: Locally Advanced or Metastatic, Unresectable Soft Tissue Sarcoma;   Sarcoma;   Soft Tissue Sarcoma
Interventions: Drug: AMG 655;   Other: Placebo
6 Recruiting A Five-Tier, Phase 2 Open-Label Study of IMC-A12 Administered as a Single Agent
Conditions: Ewing's Sarcoma /Peripheral Neuroectodermal Tumor (PNET);   Rhabdomyosarcoma;   Leiomyosarcoma;   Adipocytic Sarcoma;   Synovial Sarcoma
Intervention: Biological: IMC-A12
7 Completed Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma
Conditions: Epidemic Kaposi's Sarcoma;   Recurrent Kaposi's Sarcoma
Intervention: Drug: interleukin-12
8 Recruiting Collection of Alveolar Soft Part Sarcoma and Blood Specimens for Research
Conditions: Alveolar Soft Part Sarcoma;   Sarcoma
Intervention:
9 Recruiting Sorafenib and Dacarbazine in Soft Tissue Sarcoma
Conditions: Sarcoma;   Synovial Sarcoma;   Leiomyosarcoma;   Malignant Peripheral Nerve Sheath Tumor
Intervention: Drug: Sorafenib and Dacarbazine
10 Active, not recruiting GW786034 In Patients With Relapsed Or Refractory Soft Tissue Sarcoma
Conditions: Sarcoma;   Leiomyosarcoma;   Adipocytic Tumors;   Synovial Sarcoma
Intervention: Drug: GW786034
11 Recruiting Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung
Conditions: Osteosarcoma;   Ewing Sarcoma Family Tumors;   Malignant Fibrous Histiocytoma;   Sarcoma, Synovial;   Fibrosarcoma;   Leiomyosarcoma
Intervention: Biological: REOLYSIN®
12 Recruiting Bevacizumab and Radiation Therapy for Sarcomas
Conditions: Soft Tissue Sarcoma;   Fibrous Histiocytoma;   Liposarcoma;   Leiomyosarcoma;   Fibrosarcoma;   Synovial Sarcoma
Interventions: Drug: Bevacizumab;   Procedure: Radiation Therapy
13 Active, not recruiting Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and Sarcomas
Conditions: Neuroblastoma;   Ewings Sarcoma;   Non-Rhabdomyosarcoma Soft Tissue Sarcoma
Interventions: Drug: Vincristine;   Drug: Cyclophosphamide;   Drug: Adriamycin;   Drug: Etoposide (VP-16);   Drug: Cisplatin;   Drug: Carboplatin;   Drug: Melphalan;   Drug: Ifosfamide;   Drug: G-CSF (granulocyte-colony stimulating factor);   Drug: Mesna
14 Completed A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors
Conditions: Neuroectodermal Tumor, Primitive;   Neuroepithelioma;   Osteosarcoma;   Sarcoma;   Sarcoma, Ewing's
Intervention: Drug: vincristine, adriamycin and cytoxan, alternating with ifosfamide VP-16
15 Recruiting Phase II Study of Doxorubicin, Ifosfamide, and Bevacizumab in Sarcoma.
Conditions: Sarcoma;   Soft Tissue Sarcoma
Intervention: Drug: Avastin
16 Completed Vaccine Therapy in Treating Patients With Metastatic Cancer
Conditions: Lung Cancer;   Adult Soft Tissue Sarcoma;   Colorectal Cancer;   Bone Cancer;   Ovarian Sarcoma;   Melanoma;   Colon Cancer;   Rectal Cancer;   Breast Cancer;   Eye Cancer;   Uterine Sarcoma
Interventions: Drug: interleukin-2;   Drug: MAGE-12 peptide vaccine;   Drug: Montanide ISA-51
17 Active, not recruiting Vaccine Trial for Clear Cell Sarcoma, Pediatric Renal Cell Carcinoma, Alveolar Soft Part Sarcoma and Children With Stage IV Melanoma
Conditions: Sarcoma, Clear Cell;   Sarcoma, Alveolar Soft Part;   Renal Cell Carcinoma;   Melanoma
Intervention: Biological: GVAX
18 Completed Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone Sarcoma
Conditions: Childhood Malignant Fibrous Histiocytoma of Bone;   Sarcoma
Intervention: Drug: imatinib mesylate
19 Active, not recruiting Preoperative Thalidomide With Radiation Therapy For Patients With Low-Grade Primary Soft Tissue Sarcoma or Thalidomide With Radiation Therapy and Chemotherapy For Patients With High-Grade or Intermediate-Grade Primary Soft Tissue Sarcoma of the Arm, Leg, or Body Wall
Condition: Sarcoma
Interventions: Biological: filgrastim;   Drug: dacarbazine;   Drug: doxorubicin hydrochloride;   Drug: ifosfamide;   Drug: thalidomide;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy;   Radiation: radiation therapy
20 Recruiting Proton Radiation for the Treatment of Pediatric Bone and Non-Rhabdomyosarcoma Soft Tissue Sarcomas
Conditions: Non-Rhabdomyosarcoma Soft Tissue Sarcoma;   Bone Sarcoma
Intervention: Radiation: Proton Beam Radiation

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services